@entity8276 for XXXX : report of 55 cases.

@entity1 @entity3509 @entity292 @entity153 @entity8276
From 1966 to 1986, a total of 55 @entity1 underwent a @entity8276 (53 right and 2 left) for @entity153 . Preoperative radiotherapy was given in only 5 @entity1 . The overall operative death rate was 10.9%, but no @entity1 has died since 1975 (32 survivors). Seven @entity1 had a postoperative @entity3509 (12.7%); 4 of these @entity1 had a @entity292 . Twenty-five @entity1 had postoperative radiotherapy, 5 of whom also had chemotherapy. The actuarial survival rate, after exclusion of the 6 operative deaths, was 38% at 3 years and 23% at 5 years. Survival was correlated to regional lymph node involvement. The actuarial survival rate among @entity1 with tumoral spread to bronchial lymph nodes was 43% at 3 years. Among the 13 @entity1 with only subcarinal involvement, the actuarial survival rate was 34% at 3 years. None of the 8 @entity1 with paratracheal lymph node involvement survived more than 30 months. These results indicate that @entity8276 for @entity153 with extension to the carina is now fully justified considering the low operative mortality and the good results observed when lateral tracheal lymph nodes were not involved.
